ArticlePloS one2025
Depressive and anxiety symptoms, and their associated factors among adult, visually impaired follow-up patients attending the Hawassa University Comprehensive Specialized Hospital Eye Care and Training Center, South Ethiopia, 2024.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough the burden of depressive and anxiety symptoms among visually impaired adults has become a serious current health issue, relatively little is known in the study setting and in Ethiopia as well. This study aimed to assess the magnitude of depressive symptoms, anxiety, and their associated factors among adult, visually impaired follow-up patients of the Hawassa University Comprehensive Specialized Hospital Eye Care and Training Center, South Ethiopia, 2024.
methodsFrom 10 June to 2 August 2024, an institution-based cross-sectional study was conducted on 518 study subjects using a stratified sampling technique. Data were collected using a pretested, structured, and interviewer-administered questionnaire. The Hospital Anxiety Depressive symptoms Scale was used for assessment of depressive and anxiety symptoms among the study subjects in this study. This validated tool is composed of 14 items (7 for depressive symptoms and 7 for anxiety). The clinical and visual impairment related characteristics was extracted from their medical recording chart in daily basis. The statistical package for social science version 26 was used to analyze the data. Binary logistic regression was fitted. Variables with a p-value less than 0.05 were considered statistically significant.
resultsFrom 518 visually impaired follow-up patients who participated in the study, about 34.9% (95% CI: 29.3-41.3) and 39.4% (95% CI: 35.1-43.8) experienced some level of depressive symptoms and anxiety symptoms, respectively. Social support, levels of visual impairment, a history of eye surgery, the pattern of vision loss, and patient satisfaction with an eye care service were variables significantly associated with both depressive and anxiety symptoms. CONCLUSION AND RECOMMENDATIONS: Relatively higher burdens of depressive and anxiety symptoms were observed in study subjects. Screening common mental disorders during assessment of visual impairment is helpful. To enhance people's general health, public health programs must primarily target the most vulnerable populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.